济南有关睾丸的病(济南性生活总是很快) (今日更新中)

In a 5-4 decision announced Monday, the Supreme Court struck down a Louisiana law that severely restricted abortion in the state, marking a win for abortion rights advocates.Chief Justice John Roberts, a crucial conservative swing vote, sided with liberal Justices Breyer, Ginsburg, Sotomayor and Kagan in issuing the majority opinion.According to The Associated Press, Roberts has favored restrictions on abortion in two previous Supreme Court rulings.The decision strikes down a Louisiana law that would have required physicians who perform abortions to also have admitting privileges at a hospital within 30 miles of the abortion clinic. The law would have reduced the number of physicians in the state who were legally permitted to conduct an abortion to one.The law was nearly identical to a Texas law that was declared unconstitutional by the Supreme Court in a 2016 decision.This story is breaking and will be updated. 933

In a string of tweets on Monday morning, President Donald Trump further denied allegations made in a New York Times report that he had not paid income taxes 10 of the past 15 years.Trump insisted on Twitter that he had paid "many millions of dollars in taxes" and that he was "entitled, like everyone else, to depreciation & tax credits."According to The New York Times, which claimed to have obtained two decades of Trump's returns, the then-real estate mogul leveraged hundreds of millions of dollars that he earned from hosting "The Apprentice" into several expensive projects that have resulted in massive losses. The Times reports that while Trump said in a 2018 public filing that he made 4.9 million in revenue, his tax records indicate he lost .4 million that year. Trump then used those losses to avoid paying income taxes, the Times reports.The Times also reported that Trump paid just 0 in income taxes in 2016 and 2017, and is "personally responsible for loans and other debts totaling 1 million, with most of it coming due within four years."Trump argues that because of his "extraordinary assets," he, in fact, is "extremely well leveraged.""I have very little debt compared to the value of assets," Trump tweeted.Prior to publishing its reports, The New York Times says Trump Organization lawyer Alan Garten claimed that “most, if not all, of the facts appear to be inaccurate.” During a press conference at the White House on Sunday, Trump called the Times report "fake news." 1516

IMPERIAL BEACH, Calif. (KGTV) - Matt Henry, a father of six and avid surfer, says he's always had a positive attitude."It's partly just who I am," he says. "Before getting sick, I was so happy. I mean, if I were a puppy, I'd be wagging my tail all day long."The sickness he's referring to is an inoperable brain tumor, diagnosed four years ago. It affected his mood and personality. But it never affected his spirit."I think I had an attitude of like, this isn't gonna stop me," Henry says. "I've got six kids and a whole life to live. This is not enough to stop me."After surgery to remove part of the tumor, Henry learned to manage his symptoms. Doctors told him his tumor was growing slowly, giving him time. He decided to use that time to live his best life."I called it bucket list living," he says, and he shared his adventures with his family on his YouTube page. He also uses the hashtags #StayStoked and #InoperableMeetsUnstoppable on social media.Now he's sharing something new. Henry is part of a worldwide clinical trial for a new drug called Vorasinedib. A form of it has FDA Approval for treatment of some conditions of Leukemia.The study will see if a different version can help slow brain tumors' growth with a specific type of mutation, which Henry's has."If this trial works and then it's gonna help a lot of people, so I'd love to pave the way," he says.UC San Diego's Moores Cancer Center is one of the clinics taking part in the trial. Director of Neuro-Oncology Dr. David Piccioni says this new drug can be a way to delay harsher forms of treatment like chemotherapy or radiation."The idea behind the trial was trying to come up with something that might sort of kick the can down the road," says Dr. Piccioni. "It's a slow-growing tumor. But it is growing, and it is something (Matt) wants to do something about. And that's sort of the point of this trial."As he's going through the trial, Henry is posting videos about it. He peppers them with his sense of humor and hope. It's his way of showing that if he can keep a positive attitude through this, the rest of us can persevere through our challenges as well."I'm terminal. But the truth is, we're all terminal. I mean, life is a terminal disease. So, make it a big point to make today matter, make today count, and leave others better than you found them."Matt's family has a GoFundMe page to help pay for medical and other costs. 2415

How accurate are the coronavirus tests used in the U.S.?Months into the outbreak, no one really knows how well many of the screening tests work, and experts at top medical centers say it is time to do the studies to find out.When the new virus began spreading, the Food and Drug Administration used its emergency powers to OK scores of quickly devised tests, based mainly on a small number of lab studies showing they could successfully detect the virus.That’s very different from the large patient studies that can take weeks or months, which experts say are needed to provide a true sense of testing accuracy.The FDA’s speedy response came after it was initially criticized for delaying the launch of new tests during a crisis and after the Centers for Disease Control and Prevention stumbled in getting its own test out to states.But with the U.S. outbreak nearly certain to stretch on for months or even years, some experts want the FDA to demand better evidence of the tests’ accuracy so doctors know how many infections might be missed.There have been more than 2 million confirmed coronavirus cases in the U.S. and more than 115,000 deaths, according to data compiled by Johns Hopkins University. Cases in nearly half of U.S. states are rising.In recent weeks, preliminary findings have flagged potential problems with some COVID-19 tests, including one used daily at the White House. Faulty tests could leave many thousands of Americans with the incorrect assumption that they are virus-free, contributing to new flare-ups of the disease as communities reopen.“In the beginning, the FDA was under a lot of pressure to get these tests onto the marketplace,” said Dr. Steven Woloshin of Dartmouth College, who wrote about the issue in the New England Journal of Medicine last week. “But now that there are plenty of tests out there, it’s time for them to raise the bar.”The FDA said in a statement that it has already asked multiple test makers to do follow-up accuracy studies, although it didn’t say for how many of the more than 110 authorized screening tests. The agency also said it is tracking reports of problems. Accuracy has also been an issue with blood tests that look for signs of past infections.No screening test is 100% accurate. So details on accuracy are routinely provided for tests of all types, including seasonal flu, hepatitis, HIV and cancers. For example, rapid flu tests are known to miss 20% or more of all cases, a factor doctors weigh when treating patients who have symptoms but test negative.For now, most COVID-19 tests in the U.S. don’t give data on real-world performance, including how often the tests falsely clear patients of infection or falsely detect the virus. That information is lacking for all but a few of the roughly 80 commercial screening tests available, according to an Associated Press review.The government’s emergency authorization process “requires a lower level of evidence,” the agency said. Makers need only show that a test “may be effective” instead of the usual requirement to demonstrate “safety and effectiveness.” They would have to meet that higher threshold once the U.S. government declares the emergency over.Many of the commercial test makers submitted results from 60 samples, the minimum number required and mostly used lab-produced specimens of the virus. The FDA now recommends the use of nasal swabs or other real samples from people screened for coronavirus.Experts say larger patient studies patients are needed to assess a test’s true performance.Lab testing bears little resemblance to actual — sometimes imperfect — conditions at hospitals, clinics and testing sites noted Dr. Robert Kaplan of Stanford University.“You’re testing people in parking lots, the patients themselves are extremely anxious and often unable to follow instructions,” said Kaplan, a former associate director of the National Institutes of Health.Kaplan and others say those differences could explain why some tests are not performing as expected.Last month, the FDA warned doctors of a potential accuracy problem with Abbott Laboratories’ rapid ID Now test, which delivers results in roughly 15 minutes. The test has been lauded by President Donald Trump and used to screen the president, his staff and visitors to the White House.The FDA alert followed a preliminary report by New York University that found Abbott’s test missed between a third to one-half of infections caught by a rival test in patients screened for the virus.Abbott rejected the findings, saying the researchers did not follow the instructions for using its test. The company pointed to alternate patient studies, including its own, that have found the test successfully detects between 91% and 95% or more of virus cases when compared to other tests.But similar problems with ID NOW’s accuracy have been flagged in preliminary reports by researchers at Stanford University, Loyola University and the Cleveland Clinic.For now, the FDA is requiring Abbott to conduct follow-up studies in several different patient groups.The FDA’s emergency standards “are still high but there is a significant difference in the body of work that what would go into a submission under the normal process,” said Abbott vice president John Hackett. “Our normal process takes years to bring these out.”Requiring bigger studies of all coronavirus tests could provide valuable information, but it could also strain the FDA’s already stretched staff and resources, said Dr. Daniel Schultz, former director of the FDA’s medical device center.Dr. Colin West of the Mayo Clinic worries doctors and patients have put too much confidence in the current crop of tests, when an unknown number of patients with COVID-19 are likely receiving false negative results.Even a modest error rate can have grave consequences during an outbreak like COVID-19. West gives the example of a test that is 95% accurate at detecting the virus and is used on 1 million people. That would still result in 50,000 people being incorrectly told that they don’t have the virus.“The negative test does not mean that I’m off the hook,” West said. “We just need to maintain that level of vigilance until we have a better sense of how good these tests really can be.”___Follow Matthew Perrone on Twitter: @AP_FDAwriter.___Follow AP pandemic coverage at http://apnews.com/VirusOutbreak and https://apnews.com/UnderstandingtheOutbreak.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 6604

In a string of tweets on Monday morning, President Donald Trump further denied allegations made in a New York Times report that he had not paid income taxes 10 of the past 15 years.Trump insisted on Twitter that he had paid "many millions of dollars in taxes" and that he was "entitled, like everyone else, to depreciation & tax credits."According to The New York Times, which claimed to have obtained two decades of Trump's returns, the then-real estate mogul leveraged hundreds of millions of dollars that he earned from hosting "The Apprentice" into several expensive projects that have resulted in massive losses. The Times reports that while Trump said in a 2018 public filing that he made 4.9 million in revenue, his tax records indicate he lost .4 million that year. Trump then used those losses to avoid paying income taxes, the Times reports.The Times also reported that Trump paid just 0 in income taxes in 2016 and 2017, and is "personally responsible for loans and other debts totaling 1 million, with most of it coming due within four years."Trump argues that because of his "extraordinary assets," he, in fact, is "extremely well leveraged.""I have very little debt compared to the value of assets," Trump tweeted.Prior to publishing its reports, The New York Times says Trump Organization lawyer Alan Garten claimed that “most, if not all, of the facts appear to be inaccurate.” During a press conference at the White House on Sunday, Trump called the Times report "fake news." 1516

来源：资阳报